ABITEC Corporation has expanded its capabilities in custom synthesis to include high-purity lipids.
These lipids have been designed for use in lipid nanoparticle (LNP) therapeutics, and aim to address the limited availability of cGMP lipids in the pharma industry.
The company's newly expanded LNP offering means it can deliver custom lipids to drug developers and manufactureres from the mg to kg scale.
LNPs are essential in the targeted delivery of many advanced therapeutics and vaccines, but formulations containing LNPs must contain ultra-pure lipids, which are often difficult to design and acquire.
According to ABITEC, there is also a lack of tailored support in this area, along with the threat of unpredictable lead times.
Therefore, the company is addressing these issues to provide those requiring high-quality lipids with what they need.
ABITEC's CEO, Jeff Walton, commented: "This launch significantly expands ABITEC’s functional lipids manufacturing capabilities to include custom lipid synthesis for the formulations of LNPs and other highly functional drug delivery platforms and technologies."
"ABITEC customers can now access research-grade and cGMP lipids specifically designed to meet their unique applications requirements. We look forward to continually supporting our customers with advanced technologies to help overcome complex challenges and enable enhanced therapeutic outcomes."
Dr Donald Kelemen, Chief Scientific Officer, Pharmaceutical Sciences, ABITEC, added: "Acquiring Larodan AB in 2020 enhanced our portfolio with world-class lipid synthesis facilities at the Karolinska Institute, Stockholm, Sweden. Building on Larodan's 50-year legacy of producing ultra-pure lipid standards, our facilities are now an industry beacon of innovation and quality."
"With these facilities and a team of experienced PhD scientists, we’re optimally positioned to develop next-gen lipids for state-of-the-art drug formulations. Our continued investment and expansion underscore our commitment to pharmaceutical science innovation and delivering superior solutions to our global clients."
